Showing 1 - 10 of 30
This paper analyzes the impact of anticipated old age support, provided by children to parents, on intra-family transfers and education. We highlight an education motive for remittances, according to which migrants have an incentive to invest in their siblings' education via transfers to...
Persistent link: https://www.econbiz.de/10011647682
Persistent link: https://www.econbiz.de/10011853191
We provide a normative analysis of endogenous student and worker mobility in the presence of diverging interests between universities and governments. Student mobility generates a university competition effect which induces them to overinvest in education, whereas worker mobility generates a...
Persistent link: https://www.econbiz.de/10009011793
Persistent link: https://www.econbiz.de/10011751683
Persistent link: https://www.econbiz.de/10009672235
Persistent link: https://www.econbiz.de/10003353811
We develop a multiple-events model and exploit within and between country variation in the timing, type and level of intensity of various non-pharmaceutical interventions to study their dynamic effects on the daily incidence of COVID-19 and on population mobility patterns across 135 countries....
Persistent link: https://www.econbiz.de/10012225440
We develop a multiple-events model and exploit within and between country variation in the timing, type and level of intensity of various non-pharmaceutical interventions to study their dynamic effects on the daily incidence of COVID-19 and on population mobility patterns across 135 countries....
Persistent link: https://www.econbiz.de/10012227934
In the education literature, it is generally acknowledged that both credit and insurance for students are rationed. In order to provide a rationale for these observations, we present a model with perfectly competitive banks and risk averse students who have private information on their ability...
Persistent link: https://www.econbiz.de/10009012186
Over the first half of March 2021, the majority of European governments suspended Astrazeneca's Vaxzevria vaccine as a precaution following media reports of rare blood clots. We analyse the impact of the European Medicines Agency's (EMA) March 18th statement assuring the public of the safety of...
Persistent link: https://www.econbiz.de/10012585624